Nathalie Harder

Title: Nathalie Harder: Innovator in Cancer Recurrence Prediction

Introduction

Nathalie Harder is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of medical technology, particularly in cancer research. With a total of 3 patents, her work focuses on innovative systems that enhance patient care and treatment outcomes.

Latest Patents

One of Nathalie Harder's latest patents is a system for predicting the recurrence of cancer in patients. This system utilizes advanced imaging techniques to analyze prostate tissue samples. The first slice of the tissue is stained to differentiate between luminal epithelial cells and basal epithelial cells, followed by capturing a digital image. A second slice is stained to identify M1 and M2 type macrophages, and another digital image is taken. The system then analyzes these images to define regions of non-intact glands and intact gland regions, as well as stroma regions. It identifies influence zones between these regions and counts macrophages in the corresponding tissue. Based on this count, the system determines a score that indicates the likelihood of PSA recurrence in the patient.

Career Highlights

Nathalie Harder is currently employed at Definiens AG, a company known for its innovative solutions in medical imaging and diagnostics. Her work at Definiens AG has positioned her as a key player in the development of technologies that improve cancer treatment and patient monitoring.

Collaborations

Nathalie collaborates with Maria Athelogou, who is also involved in advancing medical technologies. Their partnership exemplifies the importance of teamwork in driving innovation in the healthcare sector.

Conclusion

Nathalie Harder is a trailblazer in the field of cancer research, with her innovative systems poised to make a significant impact on patient care. Her contributions through her patents and work at Definiens AG highlight the vital role of inventors in advancing medical technology.